Clinical trial Recruiting at 1 site Interventional Ages 4 to 9

Pulpotomy vs Pulpectomy for painful baby teeth in children

Official title: Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis: A Non-inferiority Randomised Controlled Trial

Run by Qatar University · NCT06904781 · Data updated 2026-11-12

This study tests whether pulpotomy can work as well as pulpectomy for treating painful, living primary molars in kids aged 4–9.

More Pulpitis - Irreversible trials

Quick facts

Study typeInterventional
Ages4 Years to 9 Years
SexAll
Enrollment80 (estimated)
SponsorQatar University
Academic / other
Locations2 sites (Irbid and 1 other locations)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedAugust 13, 2026
Trial IDNCT06904781 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4–9 years who are healthy/cooperative (ASA I–II) with a permanent, living primary molar showing symptoms of irreversible pulpitis and suitable for stainless steel crowns.

Probably not a fit

Patients with signs of infection, non-vital pulp, periapical radiolucency, or significant root resorption are not eligible and may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a parallel, open-label randomized trial comparing pulpotomy to pulpectomy in vital primary molars diagnosed with symptomatic irreversible pulpitis. About 80 teeth in cooperative children will be randomized 1:1 to receive either pulpotomy or pulpectomy and followed over two years. The trial aims to determine non-inferiority of pulpotomy relative to pulpectomy using standard restorative and follow-up procedures. Eligibility requires healthy, cooperative children with a vital pulpal diagnosis and teeth suitable for stainless steel crowns. Outcomes focus on clinical and radiographic success, tooth retention, and patient tolerance.

Why it matters

Potential benefit: If pulpotomy proves non-inferior, many young children could benefit from a simpler, faster treatment that preserves sensation and reduces chair time.

How similar studies have gone: There is growing interest in vital pulp therapy for teeth with irreversible pulpitis, but data in primary teeth are limited and this trial addresses a gap in evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Healthy (ASA I and II) co-operative children (Frankl Scale + and ++) between the ages of four and nine years.
2. Participants have symptoms typical of irreversible pulpitis in one of the primary molars.
3. The pulp of the affected primary molar is vital.
4. Radicular pulp health is confirmed by attainment of radicular pulp haemostasis within 6 minutes of coronal pulp amputation.
5. The affected primary molars can be restored with full coverage stainless steel crowns.
6. Any physiologic root resorption, if present, is less than ⅓ the root length.

Exclusion Criteria:

1. Clinical examination of affected primary molar reveals signs of pulpal infection (e.g. pathologic tooth mobility, parulis/fistula, or soft tissue swelling).
2. Pre-operative periapical radiograph suggests presence of periapical radiolucency or pathologic root resorption.
3. Visual examination of pulp tissue after deroofing reveals signs of necrosis (e.g. avascular/minimally bleeding pulp tissue or yellowish necrotic areas/purulent exudate).
4. Signs of extensive radicular pulp inflammation i.e., root pulp bleeding continues even after 6-min.
5. Parents not willing to place full coverage crowns post-treatment.
6. Clinical diagnosis of irreversible pulpitis between two adjacent primary molars is not sharply defined.
7. Unable to perform clinical procedure under rubber dam

Where it's running

  • Jordan University of Science and Technology
    Irbid, Jordan
    Recruiting
  • Primary Health Care Corporation
    Doha, Qatar
    Active not recruiting

Study contacts

  • Principal investigator: Nebu Philip, MDS, PhD — Qatar University
  • Study coordinator: Nebu Philip, MDS, PhD
  • Email: nphilip@qu.edu.qa
  • Phone: +974-44037319

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.